Haemonetics
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell Haemonetics and other ETFs, options, and stocks.About HAE
Haemonetics Corp. engages in the development and distribution of hematology products and solutions. It operates through the following segments: Plasma, Blood Center, and Hospital.
HAE Key Statistics
Stock Snapshot
The current Haemonetics(HAE) stock price is $83.49, with a market capitalization of 3.91B. The stock trades at a price-to-earnings (P/E) ratio of 24.36.
On 2025-12-13, Haemonetics(HAE) stock moved within a range of $82.07 to $84.51. With shares now at $83.49, the stock is trading +1.7% above its intraday low and -1.2% below the session's peak.
Trading activity shows a volume of 932.03K, compared to an average daily volume of 847.04K.
The stock's 52-week range extends from a low of $47.32 to a high of $87.32.
The stock's 52-week range extends from a low of $47.32 to a high of $87.32.
HAE News
JPMorgan analyst Rohin Patel raised the firm’s price target on Haemonetics (HAE) to $74 from $62 and keeps a Neutral rating on the shares. The firm updated the...
Haemonetics Corporation’s HAE impressive Hospital business recovery is poised to drive growth in the upcoming quarters. The robust uptake of the NexSys PCS syst...
Haemonetics (HAE) has quietly rallied, with shares up roughly 23% over the past month and more than 55% in the past 3 months, prompting investors to recheck the...
